Overview
FrançaisRead this article from a comprehensive knowledge base, updated and supplemented with articles reviewed by scientific committees.
Read the articleAUTHORS
-
Catherine FOUCAUD-SCHEUNEMANN: INRA Research Fellow, Microbiology and Food Chain Department Versailles-Grignon Research Centre
-
Sandra HELINCK: Senior lecturer at AgroParisTech
INTRODUCTION
Microorganisms are microscopic, ubiquitous living beings that make up the Earth's largest biomass. They are thought to have appeared around 3.8 billion years ago, and their discovery, which benefited from advances in optics, dates back to the 17th century.
Above all, they are essential to the balance of the biosphere, participating in nature's basic cycles, but they can also be harmful. They are also widely used in the production of goods and services in the context of biotechnologies.
It was with the production of fermented foods that the empirical use of micro-organisms for food preservation heralded the birth of biotechnology back in Neolithic times. Since then, advances in microbiology initiated in the 19th century by Louis Pasteur in France, as well as major advances in genetics and other fields of biology, have contributed to the emergence and development of modern biotechnologies. Today, although the question of what constitutes biotechnology remains open, the term refers to technologies that exploit cellular or molecular processes through genetic engineering.
In addition, biotechnologies, whether traditional (fermentation, enzyme engineering, strain selection, etc.) or new-generation (genetic engineering, nanotechnologies, genomics, proteomics), are increasingly being integrated into industrial processes for transforming materials, synthesizing and controlling new products.
It is against this backdrop that this article provides an overview of the use of micro-organisms in the biotechnology sector. After presenting the main characteristics of micro-organisms and biotechnologies, and highlighting points for further thought or research by the reader, we will look at biotechnologies in their fields of application, i.e. health, food, agriculture and the environment, before concluding by opening up the debate.
Exclusive to subscribers. 97% yet to be discovered!
You do not have access to this resource.
Click here to request your free trial access!
Already subscribed? Log in!
The Ultimate Scientific and Technical Reference
This article is included in
Bioprocesses and bioproductions
This offer includes:
Knowledge Base
Updated and enriched with articles validated by our scientific committees
Services
A set of exclusive tools to complement the resources
Practical Path
Operational and didactic, to guarantee the acquisition of transversal skills
Doc & Quiz
Interactive articles with quizzes, for constructive reading
Microorganisms at the heart of biotechnology
Also in our database
Bioprocesses" database
Bibliography
Economic data
In 2005, global biotech sales amounted to just over 63 billion US dollars for some 4,500 companies.
In Europe, the main biotech innovators are the UK, Germany, France, Sweden, Switzerland and Denmark. European companies, numbering 1,600, employ around 40,000 people and are concentrated in 18 countries. They generate global sales of 11.5 billion US dollars, or 16% of the biotech market, 5 times less...
Websites
http://www.europabio.org/ (European association promoting innovation in biotechnologies and bio-industries)
http://www.france-biotech.org/ (French association of biotechnology companies and their partners)
Exclusive to subscribers. 97% yet to be discovered!
You do not have access to this resource.
Click here to request your free trial access!
Already subscribed? Log in!
The Ultimate Scientific and Technical Reference